Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database
- 1 August 2017
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 218, 327-334
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: A 10-year nationwide population-based prospective cohort studyJournal of Affective Disorders, 2013
- A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: A one-year mirror-image study with national claim-based database in TaiwanJournal of Psychiatric Research, 2012
- Bipolar disorderBMJ, 2012
- A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar DisorderClinical Neuropharmacology, 2011
- Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability reviewExpert Opinion on Drug Safety, 2010
- Lamotrigine in bipolar disorder: Results of a mirror-image evaluation using the NIMH Lifechart-MethodologyJournal of Affective Disorders, 2009
- Long-Acting Injectable Risperidone and Hospital ReadmissionThe Journal of Clinical Psychiatry, 2009
- Depot antipsychotic medications in bipolar disorder: a review of the literatureActa Psychiatrica Scandinavica, 2007
- Rapid Cycling Bipolar DisorderCNS Drugs, 2005
- Bipolar DisorderNew England Journal of Medicine, 2004